Effect of leukotriene C4 on theophylline disposition in guinea pigs.
The pharmacokinetics of theophylline in acutely ill patients show wide intraindividual variability associated with the severity of clinical status. To investigate the mechanism of this variability, we studied the effects of leukotriene C4 (LTC4)-induced pathophysiologic changes on the disposition of theophylline. The plasma concentration-time profiles were measured after simultaneous intravenous bolus injection of theophylline and antipyrine in guinea pigs. The animals received 5 micrograms/kg of LTC4 intravenously 60 min later. The plasma theophylline concentration 30 min after LTC4 treatment was significantly lower (p less than 0.05) than that of nontreated control animals, whereas the plasma antipyrine concentration at that time was not affected. In addition, the treated animals showed significantly slower declines in plasma concentrations of both drugs (0.0805 +/- 0.0199 and 0.291 +/- 0.020 h-1 for theophylline and antipyrine, respectively, mean +/- SEM) than did controls (0.197 +/- 0.010 and 0.439 +/- 0.028 h-1). Leukotriene C4 treatment also induced moderate bronchoconstriction and metabolic acidosis, increased blood hemoglobin concentration and hematocrit, and decreased concentration of serum proteins. In connection with these changes, the plasma unbound fraction of theophylline increased significantly (p less than 0.001, 94.4 +/- 3.3% in treatment versus 58.2 +/- 4.4% in control), but that of antipyrine was unchanged (94.9 +/- 3.0% in treatment versus 92.1 +/- 0.9% in control). These findings indicated that an increase in the volume of distribution was responsible for the abrupt change in plasma theophylline concentration following LTC4 treatment, and the apparent change in the volume of distribution was estimated as 26.1 +/- 5.6%.(ABSTRACT TRUNCATED AT 250 WORDS)
Tanigawara
Y
Y
Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Japan.
Yano
I
I
Yasuhara
M
M
Hori
R
R
D000628:Aminophylline / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics; D000818:Animals; D000983:Antipyrine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics; D001784:Blood Gas Analysis / Q000706:statistics & numerical data; D016084:Bronchoconstriction / Q000187:drug effects; D002851:Chromatography, High Pressure Liquid / Q000295:instrumentation / Q000379:methods / Q000706:statistics & numerical data; D006168:Guinea Pigs; D006400:Hematocrit; D016013:Likelihood Functions; D008297:Male; D011485:Protein Binding / Q000187:drug effects; D012044:Regression Analysis; D013189:SRS-A / Q000008:administration & dosage / Q000494:pharmacology*; D013806:Theophylline / Q000097:blood / Q000493:pharmacokinetics*; D013997:Time Factors
D013189:SRS-A; D000628:Aminophylline; D013806:Theophylline; D000983:Antipyrine